
Company studio and early-stage investor that designs, builds and funds startups with hands-on founder support

Life science venture firm backing biotech and medtech founders through to commercialisation

Founded in 2012, Lightstone Ventures puts money into biotech and medtech founders who are turning scientific breakthroughs into treatments and devices. The firm says it looks for first-in-class drugs across every modality, from chemical compounds and biological drugs to cell and gene treatments, and that it prefers people to ideas: the team sees the quality of a company's founders as what decides its success.
Its stated focus includes the central nervous system, immunology (with particular interest in autoimmune disease), next-generation approaches to cancer, and eye disease. It also looks for founders working where technology, medicine and consumer health meet, including personalized medicines and targeted therapeutics built on data analytics and scientific platforms, with applications in immunology, cardiovascular disease, neurology and ophthalmology.
Lightstone says its partners have close to a century of combined experience building companies, and that they work with founders on day-to-day operations and strategy and not only on funding. The firm describes its capital as patient, meant to carry a company through its whole life cycle from start-up to commercialization. Its approach is thesis-driven: it studies key market sectors, searches for disruptive technologies and builds relationships with leading experts in each field.
With offices in the United States and Ireland, the firm says it can open up non-American strategic partners and funding sources, and explore development and commercialization routes outside the home market.
Its portfolio and track record include a clinical-stage maker of treatments for serious and rare diseases that went public in 2013, a company applying deep learning to naturally protective antibodies for hard-to-treat diseases, a developer of long-acting pain relief for use after surgery, and an immuno-oncology company. Team members also say they have been involved in many of the larger venture-backed life science exits of the past decade.
Lightstone Ventures is a healthcare venture capital firm founded in 2012. It invests in founders who turn scientific breakthroughs into therapies and medical technology, and it stays with them through the life of the company.
Founders developing first-in-class drugs across small molecules, biologics and cell and gene therapies, plus medical device teams. Disease areas named include the central nervous system and immunology.
Summary written by TrustList from the business's own published information, Nov 2026.
2 images - click to enlarge
Lightstone Ventures is ranked on 6 TrustList rankings: #6 on 1, #9 on 1, #13 on 1, #14 on 1, #17 on 1 and #18 on 1.
Every ranking orders its listings by their reviews, how complete the profile is and the Trust Score. Lightstone Ventures has no reviews yet and 3 of the 10 profile details we look for. Where no listing on a page has been reviewed, the order follows the profiles alone.
It is one of 3 here listing biotech.
Of the 19 here, 3 also cover biotech and 3 also cover SaaS; 11 also work in London and 10 also work in New York City.
Behind Greencoat Capital, ahead of ATX Venture Partners.
It is one of 2 here listing biotech.
Of the 48 here, 11 also cover partners and 6 also cover series a; 11 also work in San Francisco and 10 also work in Munich.
Behind Greencoat Capital, ahead of ENGIE New Ventures.
Of the 52 here, 14 also cover seed stage and 14 also cover healthtech; 15 also work in Boston and 10 also work in Silicon Valley.
Behind Brandon Capital's Medical Research Commercialisation Fund, ahead of CureDuchenne Ventures.
It is one of 3 here listing biotech.
Of the 53 here, 9 also cover growth stage and 9 also cover fintech; 16 also work in Hong Kong and 15 also work in Shanghai.
It is one of 12 here listing biotech.
Of the top 63 here, 9 also cover artificial intelligence and 9 also cover series; 12 also work in Chicago and 10 also work in Los Angeles.
Behind Star Mountain Capital, ahead of Optum Ventures.
It is one of 6 here listing biotech.
Of the top 71 here, 12 also cover early stage and 10 also cover pre seed; 5 also work in Tel Aviv.
Behind QuestVC.
As of 2026-11-16. Organic ranks only; sponsored placements are never ranks. How TrustList ranks
Used it? Your experience helps other buyers decide.
Write a reviewNo questions yet. Be the first to ask about Lightstone Ventures.
Similar listings buyers compare against this one.

Company studio and early-stage investor that designs, builds and funds startups with hands-on founder support

Semiconductor and display equipment maker that also invests in startups through venture and research programmes

Medical device manufacturer making implants and therapies for heart, cancer and spinal conditions

Semiconductor and sensing company selling components and design tools to engineers in industrial, automotive and healthcare markets

Venture arm of a crypto exchange investing in early-stage web3 and blockchain startups

Global software investor backing growth-stage technology companies with capital and in-house operating specialists

Citi's corporate venture arm investing in and partnering with financial services startups

Global private equity investor working with management teams to grow and transform businesses
Everything here links back to the same verified catalogue. Pick your next stop.